Clinical application of preoperative shear wave dispersion for prediction of post liver failure in patients with hepatocellular carcinoma after hepatectomy
Restricted accessResearch articleFirst published online December 12, 2023
Clinical application of preoperative shear wave dispersion for prediction of post liver failure in patients with hepatocellular carcinoma after hepatectomy
The aim in this study was to determine the efficacy of shear wave dispersion (SWD) technique for the prediction of post hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma after hepatectomy and develop an SWD based risk prediction model.
METHODS & MATERIALS:
We prospectively enrolled 205 consecutive patients who were scheduled to undergo hepatectomy for hepatocellular carcinoma (HCC), pre-operative SWD examination, laboratory data and some other clinicopathological tests were collected. The risk factors of PHLF were identified according to univariate and multivariate analysis, a predictive model was established based on logistic regression analyses.
RESULTS:
SWD examination was successfully performed in 205 patients. PHLF occurred in 51 patients (24.9%), including 37/11/3 patients with Grade A/B/C, respectively. There was a high correlation between SWD value of liver and liver fibrosis stage (r = 0.873, p < 0.05). Patients with PHLF has a higher median SWD value of liver than patients without PHLF [17.4 vs 14.7 (m/s)/kHz, p < 0.05]. The SWD value of liver, total bilirubin (TB), international normalized ratio of prothrombin time (INR) and splenomegaly were significantly related to PHLF based on the multivariate analysis. A new prediction model (PM) for PHLF was established (PM = –12.918 + 0.183× SWD + 6.668× INR +0.100×TB+1.240×splenomegaly). The optimal cutoff value of SWD for predicting PHLF was 16.7 (m/s)/kHz. The area under the curve (AUC) of the PM for PHLF was 0.833, which was higher than that of SWD, INR, Forns, FIB4, APRI (p < 0.005, respectively).
CONCLUSION:
SWD is a promising and reliable method for PHLF prediction in patients with HCC who were undergoing hepatectomy. Compared with SWD, Forns, APRI and FIB-4, PM demonstrate better efficacy for preoperative PHLF prediction.
SungH, FerlayJ, SiegelR L, LaversanneM, SoerjomataramI, JemalA, et al. Global cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J], CA Cancer J Clin2021;71(3):209–49.
2.
HeimbachJK, KulikLM, FinnRS, SirlinCB, AbecassisMM, RobertsLR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma [J], Hepatology2018;67(1):358–80.
3.
LiuJY, EllisRJ, HuQL, CohenME, HoytDB, YangAD, et al. Post hepatectomy liver failure risk calculator for preoperative and early postoperative period following major hepatectomy [J], Ann Surg Oncol2020;27(8):2868–76.
4.
RahbariNN, GardenOJ, PadburyR, Brooke-SmithM, CrawfordM, AdamR,et al. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS) [J], Surgery2011;149(5):713–24.
5.
LamCM, FanST, LoCM, WongJMajor hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test [J], Br J Surg1999;86(8):1012–7.
6.
LevesqueE, MartinE, DudauD, LimC, DhonneurG, AzoulayDCurrent use and perspective of indocyanine green clearance in liver diseases [J], Anaesth Crit Care Pain Med2016;35(1):49–57.
7.
BerzigottiA, ReigM, AbraldesJ G, BoschJ, BruixJPortal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis [J], Hepatology61(2) 2015), 526–36.
8.
TsujitaY, SofueK, KomatsuS, YamaguchiT, UeshimaE, UenoY, et al. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion [J], Eur J Radiol2020;130, 109189.
9.
ShenY, ShiG, HuangC, ZhuX, ChenS, SunH, et al. Prediction of post-operative liver dysfunction by serum markers of liver fibrosis in hepatocellular carcinoma [J], PLoS One.e2015;10(10):0140932.
10.
de MartelC, Maucort-BoulchD, PlummerM, FranceschiSWorld-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma [J], Hepatology2015;62(4):1190–200.
11.
HobeikaC, FuksD, CauchyF, GoumardC, SoubraneO, GayetB, et al. Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey [J], Br J Surg2020;107(3):268–77.
12.
HerrmannE, de LédinghenV, CassinottoC, ChuWC, LeungVY, FerraioliG, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis [J], Hepatology2018;67(1):260–72.
13.
PeschelG, GrimmJ, BuechlerC, GunckelM, PollingerK, AschenbrennerE, et al. Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy [J], Clin Hemorheol Microcirc2021;79(4):541–55.
14.
BergWA, CosgroveDO, DoréCJ, SchäferFK, SvenssonWE, HooleyRJ, et al. Shear-wave elastography improves the specificity of breast US: The BE1 multinational study of 939 masses [J], Radiology2012;262(2):435–49.
15.
KumarV, DenisM, GregoryA, BayatM, MehrmohammadiM, FazzioR, et al. Viscoelastic parameters as discriminators of breast masses: Initial human study results [J], PLoS One2018;13(10):e0205717.
16.
JesperD, FiedlerS, KlettD, WaldnerM J, SchellhaasB, ZundlerS, et al. Shear wave dispersion imaging for the characterization of focal liver lesions - a pilot study [J]. Ultraschall Med. 2021.
17.
LeeDH, LeeJY, BaeJS, YiNJ, LeeKW, SuhKS, et al. Shear-wave dispersion slope from US shear-wave elastography: Detection of allograft damage after liver transplantation [J], Radiology293(2) 2019), 327–33.
18.
FerraioliG, MaiocchiL, DellafioreC, TinelliC, AboveE, FiliceCPerformance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique [J], Eur J Gastroenterol Hepatol2021;33(1):89–95.
19.
ScheuerPJClassification of chronic viral hepatitis: A need for reassessment [J], J Hepatol1991;13(3):372–4.
20.
BedossaPPathology of non-alcoholic fatty liver disease [J], Liver Int2017;37(Suppl 1):85–9.
21.
IshizawaT, HasegawaK, AokiT, TakahashiM, InoueY, SanoK, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma [J], Gastroenterology2008;134(7):1908–16.
22.
BarrRG, FerraioliG, PalmeriML, GoodmanZD, Garcia-TsaoG, RubinJ, et al. Elastography assessment of liver fibrosis: Society of radiologists in ultrasound consensus conference statement [J], Radiology2015;276(3):845–61.
23.
BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalAGlobal cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J], CA Cancer J Clin2018;68(6):394–424.
24.
YangJD, HeimbachJKNew advances in the diagnosis and management of hepatocellular carcinoma [J], Bmj.m2020;371, 3544.
25.
WangQ, LauWY, ZhangB, ZhangZ, HuangZ, LuoH, et al. Preoperative total cholesterol predicts postoperative outcomes after partial hepatectomy in patients with chronic hepatitis B- or C-related hepatocellular carcinoma [J], Surgery2014;155(2):263–70.
26.
FuR, QiuT, LingW, LuQ, LuoYComparison of preoperative two-dimensional shear wave elastography, indocyanine green clearance test and biomarkers for post hepatectomy liver failure prediction in patients with hepatocellular carcinoma [J], BMC Gastroenterol2021;21(1):142.
27.
ZhangZ Q, YangB, ZouH, XiongL, MiaoXY, WenY, et al. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients [J], Medicine (Baltimore)2019;98(15):e15168.
28.
DasariBVM, HodsonJ, RobertsKJ, SutcliffeRP, MarudanayagamR, MirzaDF, et al. Developing and validating a pre-operative risk score to predict post-hepatectomy liver failure [J], HPB (Oxford)2019;21(5):539–46.
29.
ZhengJ, GuoH, ZengJ, HuangZ, ZhengB, RenJ, et al. Two-dimensional shear-wave elastography and conventional US: The optimal evaluation of liver fibrosis and cirrhosis [J], Radiology2015;275(1):290–300.
30.
JungEM, KammererS, BrandensteinM, PutzFJ, StroszczynskiC, JungFHigh resolution flow (HR Flow) and Glazing Flow in cases of hepatic flow changes: Comparison to color-coded Doppler sonography (CCDS) [J], Clin Hemorheol Microcirc2021;79(1):3–17.
31.
ShenY, ZhouC, ZhuG, ShiG, ZhuX, HuangC, et al. Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma [J], J Gastrointest Surg2017;21(9):1471–9.
32.
ZhangXQ, ZhengRQ, JinJY, WangJF, ZhangT, ZengJ US shear-wave elastography dispersion for characterization of chronic liver disease [J]. Radiology. 2022:212609.
33.
RusG, FarisI H, TorresJ, CallejasA, MelchorJWhy are viscosity and nonlinearity bound to make an impact in clinical elastographic diagnosis? [J], Sensors (Basel)2020;20(8).
34.
ChenS, SanchezW, CallstromMR, GormanB, LewisJT, SandersonSO, et al. Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force [J], Radiology2013;266(3):964–70.
